Improving the health of our patients through groundbreaking clinical research
The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.
Current Clinical Trials:
Study: Injectable Treatment to Treat Keloids
Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.
Qualifications:
- Male and Females, 18 – 60 years old
- Have at least one keloid scar present for at least one year on the upper body, arms, or legs
Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed
To participate Please click here.
Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis
Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.
Qualifications:
- Male and Females, 18 years or older
- Current diagnosis of Plaque Psoriasis
Duration: Up to 20 weeks
Location: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Study: Evaluation of Dermal Cooling System for the Treatment of Psoriasis
Purpose: The purpose of this investigation is to evaluate the Dermal Cooling System for the treatment of Psoriasis in adult subjects, to verify that exposure to controlled cold conditions will elicit improvement in the cosmetic appearance or physical symptoms of patients affected by this skin condition.
Qualifications:
- Males and females, ages 18 or older
- Psoriasis diagnosis (if no diagnosis, can be diagnosed on site)
- Subject is willing to have skin exposed to cooling with Dermal Cooling System
Duration: Approximately 12 months
Location: Hackensack, NJ
Compensation: $50 per visit
Interested in participating in our clinical research study? Please click here.
Study: Efficacy and Safety study of RPT193 as Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis
Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.
Qualifications:
- Male and Females, 18 to 75 years old
- Clinical diagnosis of Atopic Dermatitis
- Documented history of inadequate response to a ≥1 month treatment with topical medications
Duration: Up to 7 months
Location: Hackensack, NJ
Compensation: Up to $650
Interested in participating in our clinical research study? Please click here.
Study: A Post Market Study of a 1726nm Laser System for the Treatment of Acne Vulgaris
Purpose: The purpose of this investigation is to evaluate the safety and efficacy of the Cutera® 1726 nm laser system for the treatment of moderate to severe acne. Subjects will receive 3 laser treatments at 4-week intervals. Follow-up visits will occur at approximately 7 days post each treatment (via phone) and at 12-, 26- and 52-weeks post third treatment.
Qualifications:
- Males and females, ages 16 to 60 years
- Fitzpatrick skin types I-VI with moderate or severe acne vulgaris
Duration: Approximately 17 months
Location: Hackensack, NJ
Compensation: Up to $275 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Study: Non-Treatment Study for Hip Dip Images
Purpose: Participants will go through a 15-minute photo session of their Hip Dips at sponsor photography location. The images will be used for medical education or clinical research only.
Qualifications:
- Females, ages 18 or older
- BMI <27
- No tattoos, prominent scarring, or excessive cellulite
- Must be fully vaccinated
Duration: Approximately 15 minutes
Location: Parsippany, NJ
Compensation: $200
Interested in participating in our clinical research study? Please click here.
Interested in participating in our clinical research study? Please click here.
What to expect during a clinical trial:
- Access to new investigational treatments before they are made widely available
- Financial compensation for participation
- An opportunity to contribute to the advancement of medical science through research
- Study visits conducted by a trained and dedicated research team
- Adherence to strict industry and safety standards.
- Evaluations performed by one of our certified provide
To learn more contact: Diana Aranzazu, [email protected], 609-219-5621
Schedule A Consultation
Contact UsAll Rights Reserved. Web Design & Internet Marketing by Studio III